CPhI Worldwide in Frankfurt, 5th to 6th November 2019
Upperton will be exhibiting CPhI Worldwide in Frankfurt this November, our stand will be located at the Department of International Trade (DIT) UK Pavilion stand 41H20 within CPhI Worldwide, Hall 4. Attending CPhI on behalf of Upperton are: Dr Richard Johnson the Founder & CEO, Paul Kelsall Director of Clinical Manufacturing, Dr Ian Lafferty Technical Consultant and Klara Fisken Business Development Associate.
We are looking forward to meeting both new and existing clients on our stand. So if you have an API which requires formulation development or clinical manufacture, please contact us to book an appointment or alternatively drop by our exhibition stand to talk to Upperton’s team.
Upperton have been investing in equipment to enhance our capabilities in manufacturing final dosage forms. Our current focus is in enhancing/ increasing out put in our tabletting capabilities. With this in mind we recently acquired a new cutting edge tablet press, a Futorque X by KG-Pharma, allowing us the capability of producing up to 130,000 tablets per hour or supporting DoE and research studies with minimal material.
At CPhI we’ll be unveiling our latest purchase in equipment for enhancing our tabletting capabilties.
CPhI Worldwide Conference
CPhI Worldwide is the world’s largest pharmaceutical exhibition, housing six zones representing each stage of the pharmaceutical supply chain – from APIs, machinery and packaging to outsourcing and biopharmaceuticals; Upperton’s stand can be found in Hall 4 (APIs). With 45,000 visiting attendees and 2,500 international exhibitors, CPhI Worldwide is a useful place to network and source pharma solutions from all over the world through the course of its three days.